Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS. - Jang HJ; Urrutia G; Orskov AD; Kim HJ; Nelson SA; Nguyen AV; Lee H; Burgos RS; Johnson BK; Wegener M; Becker K; Adams M; et al. (BioRxiv : the preprint server for biology, 2024)